The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

FOREX-Dollar falls on Biden transition, vaccine hopes; kiwi soars

Tue, 24th Nov 2020 12:09

* Graphic: World FX rates in 2020 https://tmsnrt.rs/2RBWI5E

By Saikat Chatterjee

LONDON, Nov 24 (Reuters) - The Australian dollar rose to a
two-and-a-half-month high and the euro gained on Tuesday as U.S.
President Donald Trump accepted the transition to a Joseph Biden
presidency, which may include former Federal Reserve Chair Janet
Yellen as Treasury secretary.

Appetite for riskier assets was evident across the board.
Stocks and oil rose as progress made on COVID-19 vaccines, which
had underpinned Wall Street overnight, boosted optimism about a
quicker revival for the global economy.

Trump acknowledged the head of the General Services
Administration should go ahead with a transition to a government
led by President-elect Biden, despite plans to continue with
legal challenges.

Democratic allies to the Biden campaign said Yellen is
expected to be nominated to become Treasury Secretary. She has
called for increased government spending to lift the economy out
of a coronavirus-induced recession.

"That should be a positive appointment from the market’s
point of view, as she is expected to pursue conventional
policies," Commerzbank strategists said in a daily note.

"And as far as the fiscal package is concerned, she is
likely to listen to the Fed's demands and try and push a package
as much as possible."

Yellen has called for more fiscal spending to revive an
economy wrecked by the coronavirus pandemic. She would be the
first person to head the Treasury, the Fed and the White House
Council of Economic Advisers.

In contrast, U.S. Treasury Secretary Steven Mnuchin last
week let some of the Fed's lending programmes expire at the end
of this year, opening a feud with the central bank, which said
those emergency facilities are important to support the economy.

Against a basket of other major currencies, the
dollar weakened 0.4% to 92.13, just above Monday's 92.013, the
lowest in nearly three months.

The Australian dollar climbed 0.9% to $0.7367. The
euro gained 0.4% at $1.1894.

The euro's gains will be a concern for policymakers at
December's meeting of the European Central Bank. German Ifo data
and PMI surveys showed the European economy is struggling amid
lockdowns to slow a second wave of coronavirus
infections.

The dollar also struggled after AstraZeneca said its
COVID-19 vaccine could be about 90% effective and it would
prepare to submit data to authorities around the world,
increasing demand for risky assets.

The New Zealand dollar rose as much as 1% to a
two-year high of $0.6985, after the country's government sought
advice from the central bank on how it could help stabilise
property prices, prompting investors to unwind some bets of more
easing.

Elsewhere, cryptocurrency Bitcoin scaled a near
three-year peak of $19,000.

(Reporting by Saikat Chatterjee; Additional reporting by
Hideyuki Sano in Tokyo; editing by Kirsten Donovan, Larry King)

Related Shares

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...

3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out...

2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...

2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood canc...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.